Systematic review and meta-analysis of randomized clinical trials comparing efficacy and safety outcomes of insulin glargine with NPH insulin, premixed insulin preparations or with insulin detemir in type 2 diabetes mellitus.
about
Safety and efficacy of insulin glargine 300 u/mL compared with other basal insulin therapies in patients with type 2 diabetes mellitus: a network meta-analysisDifferences in self-monitored, blood glucose test strip utilization by therapy for type 2 diabetes mellitusHypoglycemia After Initiation of Basal Insulin in Patients with Type 2 Diabetes in the United States: Implications for Treatment Discontinuation and Healthcare Costs and UtilizationSystematic Review of the Cost Effectiveness of Insulin Analogues in Type 1 and Type 2 Diabetes Mellitus.Hypoglycemia in patients with type 2 diabetes newly initiated on basal insulin in the US in a community setting: impact on treatment discontinuation and hospitalization.Glargine insulin/gliclazide MR combination therapy is more effective than premixed insulin monotherapy in Chinese patients with type 2 diabetes inadequately controlled on oral antidiabetic drugs.Deprescribing antihyperglycemic agents in older persons: Evidence-based clinical practice guideline.Déprescription des antihyperglycémiants chez les personnes âgées: Guide de pratique clinique fondé sur les données probantes.Real-world therapeutic benefits of patients on insulin glargine versus NPH insulin.Switching basal insulins in type 2 diabetes: practical recommendations for health care providers.Clinical Benefit of Basal Insulin Analogue Treatment in Persons with Type 2 Diabetes Inadequately Controlled on Prior Insulin Therapy: A Prospective, Noninterventional, Multicenter Study.Enhanced external counterpulsation (EECP) improves biomarkers of glycemic control in patients with non-insulin-dependent type II diabetes mellitus for up to 3 months following treatment.Long-acting insulin analogues for type 1 diabetes: An overview of systematic reviews and meta-analysis of randomized controlled trials.Efficacy and Safety of Insulin Glargine 300 U/mL versus 100 U/mL in Diabetes Mellitus: A Comprehensive Review of the Literature.[Which patients from routine care use the new insulin analogue glargine U300 compared to patients with glargine U100 : A multicenter analysis of 14,123 patients with insulin glargine from die diabetes registries DPV and DIVE].Comparative effectiveness and safety of different basal insulins in a real-world setting.Insulins NPH, glargine, and detemir, and risk of severe hypoglycemia among working-age adults.
P2860
Q28078467-C53A00DA-50A1-4AEA-ABB8-AC377E99BF5FQ36928047-20861CF4-6823-41CE-A661-D10AF4F92CD9Q38639583-C83FF00F-3AC4-437A-B688-6085E65A74C6Q38983622-6906FDFB-A0E6-4CA4-BD5E-126D6DDC69CBQ39294616-18B0D0EC-C968-4D9F-B7D0-82440D22272BQ40963671-83106993-930E-4AB9-8ED0-68C01E8FAD3AQ47097108-35CA0786-52FA-4AF3-A7F0-B18AA6A95FBCQ47132365-04F02446-8385-4598-8CD0-E9D060392CE7Q47770450-4B648AF4-08AC-4496-A1BB-15D26833908BQ48088343-BB3428CB-95C1-4FB0-B3C8-72FEBCB72829Q49823996-398A80C2-F6C1-4320-967B-FAC3251304D6Q51284596-2C9700CF-7972-46DF-B017-0DB122CD1BFCQ52591845-6C0D7EF6-62B0-499F-AA4E-B5D9B1420507Q52605864-CACB2B85-EAF5-4BA5-A947-13D5853A2EC0Q52836101-0B5BF8D1-29B3-4DF0-9176-428C3AF84E95Q53484316-9D2384F6-E836-4F4A-BCC9-EEFB71504C38Q53598738-BBBE0DD2-B0DB-4A70-9555-294DD38140F3
P2860
Systematic review and meta-analysis of randomized clinical trials comparing efficacy and safety outcomes of insulin glargine with NPH insulin, premixed insulin preparations or with insulin detemir in type 2 diabetes mellitus.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Systematic review and meta-ana ...... r in type 2 diabetes mellitus.
@en
type
label
Systematic review and meta-ana ...... r in type 2 diabetes mellitus.
@en
prefLabel
Systematic review and meta-ana ...... r in type 2 diabetes mellitus.
@en
P2093
P2860
P31
P921
P1433
P1476
Systematic review and meta-ana ...... r in type 2 diabetes mellitus.
@en
P2093
Agnieszka Rogoz-Sitek
Albert Syta
Grzegorz Niesyczyński
Joanna Lis
Maciej T Malecki
Piotr Wojciechowski
Przemyslaw Rys
P2860
P2888
P304
P356
10.1007/S00592-014-0698-4
P577
2015-01-14T00:00:00Z
2015-08-01T00:00:00Z
P5875
P6179
1017730776